Individualised controlled ovarian stimulation (iCOS): maximising success rates for assisted reproductive technology patients.
about
Prevention of Ovarian Hyperstimulation Syndrome: A ReviewGonadotropin therapy in assisted reproduction: an evolutionary perspective from biologics to biotech.Recombinant human follicle-stimulating hormone (r-hFSH) plus recombinant luteinizing hormone versus r-hFSH alone for ovarian stimulation during assisted reproductive technology: systematic review and meta-analysis.Anovulatory Patients Demonstrate a Sharp Decline in LH Levels upon GnRH Antagonist Administration during IVF Cycles.Single-arm, observational study of the ease of use of a redesigned pen device to deliver recombinant human follicle-stimulating hormone (follitropin alfa) for assisted reproductive technology treatment.Serum human chorionic gonadotropin levels on the day before oocyte retrieval do not correlate with oocyte maturity.Individualized Treatment from Theory to Practice: The Private Case of Adding LH during GnRH Antagonist-based Stimulation Protocol.Does the number of oocytes retrieved influence pregnancy after fresh embryo transfer?Predictive factors for oocyte retrieval failure in controlled ovarian hyperstimulation protocols: a retrospective observational cohort study.Controlled Ovarian Stimulation with recombinant-FSH plus recombinant-LH vs. human Menopausal Gonadotropin based on the number of retrieved oocytes: results from a routine clinical practice in a real-life population.Hormonal, functional and genetic biomarkers in controlled ovarian stimulation: tools for matching patients and protocols.Predicting and preventing ovarian hyperstimulation syndrome (OHSS): the need for individualized not standardized treatment.Optimum oocyte retrieved and transfer strategy in young women with normal ovarian reserve undergoing a long treatment protocol: a retrospective cohort studyThe Ideal Stimulation Protocol: Is There One?Mild ovarian stimulation for in vitro fertilization: one perspective from the USACirculating microRNAs in follicular fluid, powerful tools to explore in vitro fertilization processIndividualized follicle-stimulating hormone dosing and in vitro fertilization outcome in agonist downregulated cycles: a systematic review.Catastrophic payment for assisted reproduction techniques with conventional ovarian stimulation in the public health sector of South Africa: frequency and coping strategies.The impact of the time interval on in-vitro fertilisation success after failure of the first attempt.Controlled ovarian stimulation with r-FSH plus r-LH vs. HMG plus r-FSH in patients candidate for IVF/ICSI cycles: An RCT.FSH dose to stimulate different patient' ages: when less is more.Age-specific serum anti-Müllerian hormone concentration in Japanese women and its usefulness as a predictor of the ovarian response.Serum substance P concentrations to predict oocyte maturation index and clinical pregnancy.The necessity to define the sub-optimal responders.Ovarian Hyperstimulation Syndrome: A Narrative Review of Its Pathophysiology, Risk Factors, Prevention, Classification, and Management.
P2860
Q26828442-C4976A36-8CE2-470A-8024-E20803FCD8DDQ30796722-F9B5D928-1114-4A14-84A6-EC60CB071DD2Q33587150-FB6DEA91-081E-4C70-B81C-D3D812724240Q33633416-1D6E874E-78A4-4DF9-A67E-2FD9E0302C44Q33734705-94479419-FED0-4FF5-BFA9-6F909BFCA082Q34125156-6EABCE81-33AB-44D1-968B-5CDC8A547477Q34421570-559F61D9-1703-4ECC-AE92-76F094CC7B79Q34606604-04CFEB52-D7F1-4A22-A0DF-9F7EDDF93779Q35681705-1CE690B3-06D8-47F0-AE0A-AF631A85C5FDQ35713241-B627AF93-E2D5-4EB5-B8CD-E19084358EB4Q35822351-CD3595C3-C414-4BB3-BEAE-BBAE1D03F395Q36112513-CD1C634C-3649-4E86-9812-AB3492CC47B4Q36192133-6D642A1A-80B2-45AB-A3E4-3D11CE5BD136Q36337216-0EBAA32C-A68C-497A-8C16-ED6F0C939C12Q36648722-567D90B5-F25E-4709-BBED-2C7F580260E4Q36824056-65B2B918-3CBE-4A1B-B44B-B986DC7F2B80Q38968422-49410447-4A74-4C5A-A1A4-E849244909CAQ40126162-8796AE78-CFFA-43B4-B1FA-B7A31A2BA16CQ45769769-8EDC0825-879F-4A0F-B308-9F876AB65A2BQ47097952-381423B9-C0DE-4E5A-B7D5-A878B7B52C65Q47102916-17CADD6E-72DB-4101-BF8C-AFDEE4257403Q47135963-F183AFEA-2BBE-4C14-B667-D406F4F70C11Q48534710-E5A096AD-524D-4717-90BC-0035E2DEB1D1Q48566473-AB1ABFD0-407B-4A27-9B35-6900EE5C4367Q55279761-05A697A7-D443-4D96-A245-20EC0F83B349
P2860
Individualised controlled ovarian stimulation (iCOS): maximising success rates for assisted reproductive technology patients.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Individualised controlled ovar ...... roductive technology patients.
@ast
Individualised controlled ovar ...... roductive technology patients.
@en
type
label
Individualised controlled ovar ...... roductive technology patients.
@ast
Individualised controlled ovar ...... roductive technology patients.
@en
prefLabel
Individualised controlled ovar ...... roductive technology patients.
@ast
Individualised controlled ovar ...... roductive technology patients.
@en
P2860
P356
P1476
Individualised controlled ovar ...... roductive technology patients.
@en
P2093
Diego Ezcurra
Ernesto Bosch
P2860
P2888
P356
10.1186/1477-7827-9-82
P577
2011-06-21T00:00:00Z
P5875
P6179
1050574215